Search

Your search keyword '"Mortara, Andrea"' showing total 199 results

Search Constraints

Start Over You searched for: Author "Mortara, Andrea" Remove constraint Author: "Mortara, Andrea" Search Limiters Full Text Remove constraint Search Limiters: Full Text
199 results on '"Mortara, Andrea"'

Search Results

1. Cardiac Rhythm Monitoring After Acute Decompensation for Heart Failure: Results from the CARRYING ON for HF Pilot Study

3. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

5. Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

6. Acute heart failure and valvular heart disease:A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

7. Survival After Invasive or Conservative Management of Stable Coronary Disease

11. Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry

13. NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population

14. Twenty-year trends in heart failure among U.S. adults, 1999–2018: The growing impact of obesity and diabetes

15. Additional file 1 of NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population

18. 554 Machine learning for prediction of in-hospital mortality in COVID-19 patients: results from an Italian multicentre study

19. Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study

22. BLITZ‐HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines.

23. JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy

25. Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study

26. The prognostic value of serial troponin measurements in patients admitted for COVID‐19

27. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, GALACTIC‐HF: baseline characteristics and comparison with contemporary clinical trials

28. Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population

29. Compassionate use of Ruxolitinib in patients with SarsCov-2 infection not on mechanical ventilation. Short-term effects on inflammation and ventilation

30. Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

32. Compassionate use of ruxolitinib in patients with SARS‐Cov‐2 infection not on mechanical ventilation: Short‐term effects on inflammation and ventilation

34. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID ‐19. Results of the Cardio‐COVID‐Italy multicentre study

35. Congenital Muscular Mitral-Aortic Discontinuity Identified in Patients With Obstructive Hypertrophic Cardiomyopathy

38. Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis

40. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology

41. Would You Prescribe Mobile Health Apps for Heart Failure Self-care? An Integrated Review of Commercially Available Mobile Technology for Heart Failure Patients

42. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology

43. Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan

46. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology

47. Incidental cardiac fibroma as first manifestation of naevoid basal cell carcinoma syndrome.

48. Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology

Catalog

Books, media, physical & digital resources